ArticlemSphere2024
Clinical, microbiological, and molecular characterization of pediatric invasive infections by
Open access · goldAbstract read
In one paragraph
Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
22.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 42 citations in OpenAlex.
- Tracing the recent evolution of Group AEmerging microbes & infections · 2026Review
- Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022-2024: a two-year analysis.Infection · 2026Article
- Sudden re-emergence ofNew microbes and new infections · 2026Article
- How Should Bacteriological Sampling Be Stratified in Paediatric Septic Arthritis? A Narrative Review with a Proposed Risk-Stratified Framework.Antibiotics (Basel, Switzerland) · 2026Review
- Comparing virulence profile of dominantInfectious diseases & immunity · 2026Article
- An ancient genome of Streptococcus pyogenes from a pre-Columbian Bolivian mummy.Nature communications · 2026Article
- Article
- Before and after the bottleneck: pediatric group A streptococcal infections in Houston, TX, from 2013 to 2023.Microbiology spectrum · 2026Article
- Clinical features and trends of severe paediatric group A streptococcal infections in Japan in the post-COVID-19 pandemic era.Epidemiology and infection · 2026Article
- Molecular epidemiology and antimicrobial susceptibility of group A Streptococcus isolated from children in Greece during 2023.Infection · 2026Article
- Cross-sectional hospital-based investigation on clinical characteristics of pediatric Group A Streptococcus isolates in a Beijing hospital from 2014 to 2023.Annals of clinical microbiology and antimicrobials · 2026Article
- Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Recurrence following invasive GAS infections in adults: Triumph of virulence or failure of immunity?Virulence · 2025Article
- Elucidating the role of group A Streptococcus genomics and pharyngeal microbiota in acute paediatric pharyngitis.Scientific reports · 2025Article
- Severe Group A Streptococcus Infection among Children, France, 2022-2024.Emerging infectious diseases · 2025Article
- Risk Factors for Severe Pediatric Invasive Group A Streptococcal Disease.JAMA network open · 2025Observational
- Article
- Molecular and Clinical Characterization of InvasivePathogens (Basel, Switzerland) · 2025Article
- Characterization ofMicroorganisms · 2025Article
- Global spread of Streptococcus pyogenes A genomics-supported narrative review.FEMS microbiology reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 10 institutions in 1 country.
Eva Ramírez de Arellano *Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Jesús Saavedra-Lozano *CIBER de Enfermedades Infecciosas (CIBERINFEC). Instituto Salud Carlos III, Madrid, Spain.
Pilar Villalón *Laboratorio de Referencia e Investigación en Taxonomía, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0003-3026-2178
Ana Jové-BlancoServicio de Pediatría, Hospital General Universitario Gregorio Marañón. Universidad Complutense, Madrid, Spain.
David GrandiosoServicio de Microbiología, Hospital Universitario La Paz, Madrid, Spain.
Jared SoteloLaboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Anna GamellServicio de Enfermedades Infecciosas, Hospital San Joan de Déu, Barcelona, Spain.
Juan José González-LópezCIBER de Enfermedades Infecciosas (CIBERINFEC). Instituto Salud Carlos III, Madrid, Spain.
Eloísa CervantesServicio de Pediatría, Hospital Virgen de la Arrixaca, Murcia, Spain.
María José GónzalezServicio de Microbiología, Hospital Universitario Niño Jesús, Madrid, Spain.
Victoria Rello-SaltorServicio de Pediatría, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Cristina EstevaServicio de Microbiología, Hospital San Joan de Dèu, Barcelona, Spain.
Francisco Sanz-SantaeufemiaServicio de Pediatría, Hospital Universitario Niño Jesús, Madrid, Spain.
Genoveva YagüeServicio de Microbiología, Hospital Virgen de la Arrixaca, Murcia, Spain.
Ángela ManzanaresServicio de Pediatría, Hospital 12 de Octubre, Madrid, Spain.
Patricia BrañasServicio de Microbiología, Hospital 12 de Octubre, Madrid, Spain.
Enrique Ruiz de GopeguiCIBER de Enfermedades Infecciosas (CIBERINFEC). Instituto Salud Carlos III, Madrid, Spain.
Jaime Carrasco-ColomServicio de Pediatría, Hospital Universitario Son Espases, Palma, Spain.
Federico GarcíaCIBER de Enfermedades Infecciosas (CIBERINFEC). Instituto Salud Carlos III, Madrid, Spain.
Emilia CercenadoServicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Isabel MelladoServicio de Pediatría y Enfermedades Infecciosas, Hospital Universitario La Paz, Fundación IdiPaz Madrid, Spain. Red de Investigación Traslación en Infectología Pediátrica (RITIP), Universidad Autónoma de Madrid, Madrid, Spain.
Elena Del CastilloServicio de Pediatría. Hospital Materno Infantil de Badajoz, Badajoz, Spain.
María Pérez-VazquezLaboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Jesús Oteo-Iglesias *Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.ORCID 0000-0003-3327-8263
Cristina Calvo *CIBER de Enfermedades Infecciosas (CIBERINFEC). Instituto Salud Carlos III, Madrid, Spain.ORCID 0000-0002-6503-3423
Spanish PedGAS-Net/CIBERINFEC GAS Study Group
Instituto de Salud Carlos III · ESHospital Universitario La Paz · ESHospital General Universitario Gregorio Marañón · ESHospital Infantil Universitario Niño Jesús · ESHospital Sant Joan de Déu Barcelona · ESHospital Universitario Virgen de la Arrixaca · ESHospital Materno-Infantil · ESHospital Universitario 12 De Octubre · ESHospital Universitario Son Espases · ESVall d'Hebron Hospital Universitari · ES
Funding
Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CIBERINFEC) CIBERINFEC AES 2022
Abstract
In December 2022, an alert was published in the UK and other European countries reporting an unusual increase in the incidence of IMPORTANCE: Group A
Indexed as
PneumoniaStreptococcal InfectionsAnti-Bacterial AgentsAntigens, BacterialBacterial Outer Membrane ProteinsChildHumansSpainStreptococcus pyogenesAnti-Bacterial AgentsAntigens, BacterialBacterial Outer Membrane ProteinschildrenGASinvasive diseaseM1UKoutbreakStreptococcus pyogenes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.